BlossomHill Therapeutics, Inc. (BLSM)Healthcare | Biotechnology | San Diego, United States | NasdaqGS
19.56 USD
-0.24
(-1.212%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 19.56 |
Hot Take ↕ | Aug. 22, 2026, 5:16 a.m. EDT
The immediate outlook is bearish due to a severe lack of liquidity and negative operating cash flow. Trading volume is less than half of the average, creating a fragile environment where price moves are easily distorted by thin order books rather than genuine demand. Fundamentally, the business is in distress with negative earnings, negative book value, and burning cash without any recent news or pipeline updates to suggest a turnaround. The absence of a dividend confirms the company is retaining all capital for operations, which are currently failing to generate positive free cash flow. With no analyst coverage and a market cap under $500 million, there is no safety net for a speculative biotech firm that is bleeding resources. |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 21.988 |
| Market Cap | 568,827,456 |
| Website | https://bhtherapeutics.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 0.22249997 |
| Address1 | 10,255 Science Center Drive |
| Address2 | Suite 200 |
| All Time High | 20.61 |
| All Time Low | 15.25 |
| Ask | 18.6 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 168,620 |
| Average Daily Volume3 Month | 335,287 |
| Average Volume | 335,287 |
| Average Volume10Days | 168,620 |
| Bid | 20.0 |
| Bid Size | 3 |
| Book Value | -57.527 |
| City | San Diego |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 19.56 |
| Current Ratio | 7.4 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 20.6104 |
| Day Low | 19.435 |
| Debt To Equity | 21.988 |
| Display Name | BlossomHill Therapeutics |
| Ebitda | -74,196,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -2.905 |
| Enterprise Value | 215,565,024 |
| Eps Trailing Twelve Months | -3.35 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 16.89875 |
| Fifty Day Average Change | 2.6612492 |
| Fifty Day Average Change Percent | 0.15748201 |
| Fifty Two Week Change Percent | 22.249996 |
| Fifty Two Week High | 20.6104 |
| Fifty Two Week High Change | -1.0503998 |
| Fifty Two Week High Change Percent | -0.050964553 |
| Fifty Two Week Low | 15.25 |
| Fifty Two Week Low Change | 4.3099995 |
| Fifty Two Week Low Change Percent | 0.2826229 |
| Fifty Two Week Range | 15.25 - 20.6104 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,786,109,400,000 |
| Float Shares | 1,434,732 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 63 |
| Fullday Change | -0.24 |
| Fullday Change Percent | -1.21212 |
| Fullday Price | 19.56 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.13181 |
| Held Percent Institutions | 0.26553 |
| Implied Shares Outstanding | 29,081,160 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,026-08-07 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | BlossomHill Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecule medicines that address medical needs in cancer treatment. Its pipeline includes BH-30643, an OMNI-EGFR inhibitor in clinical development for advanced EGFR-mutant non-small cell lung cancer (NSCLC), BH-501284, and BH-30236, a macrocyclic CLK (Cdc2-like kinase) inhibitor being evaluated in patients with relapsed or refractory acute myeloid leukemia (R/R AML) and higher-risk myelodysplastic syndrome (HR-MDS). BlossomHill Therapeutics, Inc. was incorporated in 2020 and is based in San Diego, California. |
| Long Name | BlossomHill Therapeutics, Inc. |
| Market | us_market |
| Market Cap | 568,827,456 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_700852009 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -71,085,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 575,806,968 |
| Open | 19.82 |
| Operating Cashflow | -56,886,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | (858) 732-3880 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 19.56 |
| Post Market Time | 1,787,959,804 |
| Previous Close | 19.8 |
| Price Hint | 2 |
| Price To Book | -0.34001425 |
| Profit Margins | 0.0 |
| Quick Ratio | 7.17 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.24 |
| Regular Market Change Percent | -1.21212 |
| Regular Market Day High | 20.6104 |
| Regular Market Day Low | 19.435 |
| Regular Market Day Range | 19.435 - 20.6104 |
| Regular Market Open | 19.82 |
| Regular Market Previous Close | 19.8 |
| Regular Market Price | 19.56 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 163,556 |
| Sand P52 Week Change | 0.20204377 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 29,081,160 |
| Shares Percent Shares Out | 0.0038 |
| Shares Short | 111,892 |
| Short Name | BlossomHill Therapeutics, Inc. |
| Short Ratio | 0.18 |
| Source Interval | 15 |
| State | CA |
| Symbol | BLSM |
| Total Cash | 116,003,000 |
| Total Cash Per Share | 43.869 |
| Total Debt | 23,022,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -3.35 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 16.89875 |
| Two Hundred Day Average Change | 2.6612492 |
| Two Hundred Day Average Change Percent | 0.15748201 |
| Type Disp | Equity |
| Volume | 163,556 |
| Website | https://bhtherapeutics.com |
| Zip | 92,121 |